Beware of the CAR-T Hitches
Ladika, S.
Managed Care 28(5): 35-37
2019
ISSN/ISBN: 1062-3388 PMID: 31188109 Document Number: 698700
The two CAR-T therapies approved for certain blood cancers have price tags of $475,000 and $373,000-and those prices don't include other costs for services that are integral to the treatments, such as harvesting a patient's T cells. Moreover, patients typically have a lengthy hospital stay after treatment.